Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome

Haberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and n...

Full description

Bibliographic Details
Main Authors: Silvia Ferranti, Iacopo Sardi, Milena Guidi, Chiara Lembo, Salvatore Grosso
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.648717/full
_version_ 1829503599186542592
author Silvia Ferranti
Iacopo Sardi
Milena Guidi
Chiara Lembo
Salvatore Grosso
author_facet Silvia Ferranti
Iacopo Sardi
Milena Guidi
Chiara Lembo
Salvatore Grosso
author_sort Silvia Ferranti
collection DOAJ
description Haberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and neural crest dysgenesis. We report the case of a 15-year-old female with Haberland syndrome with pharmacoresistant epilepsy who developed a World Health Organization-grade IV glioblastoma. This is the first case of pediatric glioblastoma associated with Haberland syndrome. The previously reported pediatric cases included benign brain tumors. To our knowledge, this is the fifth case of brain tumor associated with encephalocraniocutaneous lipomatosis and the second case of glioblastoma associated with this syndrome. The hypothesis that Haberland syndrome is associated with an increased risk of tumor development is intriguing, although the rarity of the condition is nowadays preventing us from drawing definitive conclusions about this potential link between the two entities. Further studies are needed to establish the real relationship between encephalocraniocutaneous lipomatosis and the risk of brain tumors.
first_indexed 2024-12-16T10:01:17Z
format Article
id doaj.art-b199fa03c9e74f73ba056d93aaa499dd
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-16T10:01:17Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-b199fa03c9e74f73ba056d93aaa499dd2022-12-21T22:35:46ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-03-01910.3389/fped.2021.648717648717Case Report: A Case of Glioblastoma in a Patient With Haberland SyndromeSilvia Ferranti0Iacopo Sardi1Milena Guidi2Chiara Lembo3Salvatore Grosso4Department of Molecular Medicine and Development, University of Siena, Siena, ItalyDepartment of Pediatric Oncology, Meyer Children's Hospital, Florence, ItalyDepartment of Pediatric Oncology, Meyer Children's Hospital, Florence, ItalyDepartment of Molecular Medicine and Development, University of Siena, Siena, ItalyDepartment of Molecular Medicine and Development, University of Siena, Siena, ItalyHaberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and neural crest dysgenesis. We report the case of a 15-year-old female with Haberland syndrome with pharmacoresistant epilepsy who developed a World Health Organization-grade IV glioblastoma. This is the first case of pediatric glioblastoma associated with Haberland syndrome. The previously reported pediatric cases included benign brain tumors. To our knowledge, this is the fifth case of brain tumor associated with encephalocraniocutaneous lipomatosis and the second case of glioblastoma associated with this syndrome. The hypothesis that Haberland syndrome is associated with an increased risk of tumor development is intriguing, although the rarity of the condition is nowadays preventing us from drawing definitive conclusions about this potential link between the two entities. Further studies are needed to establish the real relationship between encephalocraniocutaneous lipomatosis and the risk of brain tumors.https://www.frontiersin.org/articles/10.3389/fped.2021.648717/fullHaberland syndromeencephalocraniocutaneous lipomatosisglioblastomatumorepilepsy
spellingShingle Silvia Ferranti
Iacopo Sardi
Milena Guidi
Chiara Lembo
Salvatore Grosso
Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
Frontiers in Pediatrics
Haberland syndrome
encephalocraniocutaneous lipomatosis
glioblastoma
tumor
epilepsy
title Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
title_full Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
title_fullStr Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
title_full_unstemmed Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
title_short Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
title_sort case report a case of glioblastoma in a patient with haberland syndrome
topic Haberland syndrome
encephalocraniocutaneous lipomatosis
glioblastoma
tumor
epilepsy
url https://www.frontiersin.org/articles/10.3389/fped.2021.648717/full
work_keys_str_mv AT silviaferranti casereportacaseofglioblastomainapatientwithhaberlandsyndrome
AT iacoposardi casereportacaseofglioblastomainapatientwithhaberlandsyndrome
AT milenaguidi casereportacaseofglioblastomainapatientwithhaberlandsyndrome
AT chiaralembo casereportacaseofglioblastomainapatientwithhaberlandsyndrome
AT salvatoregrosso casereportacaseofglioblastomainapatientwithhaberlandsyndrome